Skip to main content
Figure 1 | BMC Research Notes

Figure 1

From: Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report

Figure 1

Illustration of fluvastatin and telmisartan pharmacokinetics. Drug transporters and metabolizing enzymes involved in the heptaocellular handling of fluvastatin and telmisartan are depicted. Transporters in black are more likely subject of drug drug interactions. UGT uridine diphosphate glucuronosyltransferase

Back to article page